Skip to main content
An official website of the United States government

Network Clinical Trials Quality Assurance

As a sponsor and funding agency for cancer clinical trials, DCTD is required by FDA regulations to maintain a Quality Assurance program. This program includes auditing and monitoring. CTEP's Clinical Trials Monitoring Branch (CTMB) oversees monitoring and auditing of all CTEP-sponsored clinical trials, as well as select studies sponsored by the Division of Cancer Prevention (DCP). The below resources provide more information on the auditing and monitoring process.

If you have questions or to report concerns about research misconduct, please contact CTMB at one of the following email addresses:

Auditing and Monitoring Guidelines

NCTN and NCORP Auditing Guidelines
ETCTN and Early Phase CTMS-Monitored Studies
Good Clinical Practice (GCP) Guidelines

International Council for Harmonisation (ICH) Efficacy Guideline for GCP

  • Updated:
Email